A novel pseudo-five-component synthesis, molecular docking analysis, ADMET and drug likeness studies of new 3,4-dihydro-2 H -pyrrole derivatives as potent HIF-1α inhibitors
RSC Advances · 2026 · 16 (35) · 36287-36297
DOI: 10.1039/d6ra04116g ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Nesa Roshani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Organic Chemistry Department, Faculty of Chemistry, University of Guilan Namjoo Street Rasht 41938-33697 Iran radmm@guilan.ac.ir. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: University of Guilan.
Abstract (Originalsprache)
New poly-substituted 3,4-dihydro-2 H -pyrrole derivatives were synthesized via a novel one-pot pseudo-five-component reaction in fairly high yields (68–85%).
Autor:innen und Institutionen
- Organic Chemistry Department, Faculty of Chemistry, University of Guilan Namjoo Street Rasht 41938-33697 Iran radmm@guilan.ac.ir.
ORCID-Profile: Kurosh Rad-Moghadam
Förderung
- University of Guilan
Zitieren
APA
Roshani, N., Rad-Moghadam, K., & Mehrdad, S. M. (2026). A novel pseudo-five-component synthesis, molecular docking analysis, ADMET and drug likeness studies of new 3,4-dihydro-2 H -pyrrole derivatives as potent HIF-1α inhibitors. RSC Advances, 16(35), 36287-36297. https://doi.org/10.1039/d6ra04116g
Vancouver
Roshani N, Rad-Moghadam K, Mehrdad SM. A novel pseudo-five-component synthesis, molecular docking analysis, ADMET and drug likeness studies of new 3,4-dihydro-2 H -pyrrole derivatives as potent HIF-1α inhibitors. RSC Advances. 2026;16(35):36287-36297. doi:10.1039/d6ra04116g
BibTeX
@article{Roshani2026,
author = {Roshani, Nesa and Rad-Moghadam, Kurosh and Mehrdad, Seyyed Morteza},
title = {A novel pseudo-five-component synthesis, molecular docking analysis, ADMET and drug likeness studies of new 3,4-dihydro-2 H -pyrrole derivatives as potent HIF-1α inhibitors},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {35},
pages = {36287--36297},
doi = {10.1039/d6ra04116g}
}
EUVIMED